Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis
Autor: | Zegels, B, Eastell, R, Russell, R.G.G, Ethgen, D, Roumagnac, I, Collette, J, Reginster, J.-Y * |
---|---|
Zdroj: | In Bone 2001 28(1):108-112 |
Databáze: | ScienceDirect |
Externí odkaz: |